Information Provided By: 
Fly News Breaks for March 19, 2019
TEVA
Mar 19, 2019 | 16:56 EDT
SunTrust analyst Gregg Gilbert initiated Teva with a Hold rating and a price target of $17, saying that while the new CEO Kare Schultz led a cost base restructuring effort and trying to turn around the U.S. generics business, those positive are likely factored into the stock price. The analyst adds that the company's recent delay in expecting to achieve its deleveraging target "may make existing holders anxious and potential holders more patient."
News For TEVA From the Last 2 Days
There are no results for your query TEVA
